Among outpatient cases, the rate of fluoroquinolone use increased from 35% to 61%, whereas the rate of trimethoprim-sulfamethoxazole use decreased from 53% to 32% oer the 5-year period (P <.01).
Among outpatient cases, the rate of fluoroquinolone use increased from 35% to 61%, whereas the rate of trimethoprim-sulfamethoxazole use decreased from 53% to 32% oer the 5-year period (P <.01).
门诊病人中氟喹诺酮运用在5年期间从35％增加到61％，而甲氧苄氨嘧啶的运用率从53％减少至32％(P<.01)。